Clinical trial
A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
NCT00208117 · New York State Psychiatric Institute, Other · Terminated
Key facts
| NCT number | NCT00208117 |
|---|---|
| Title | A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease |
| Official title | A Randomized Controlled Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease |
| Acronym | CHIME |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Depression, Coronary Artery Disease (CAD), Acute Coronary Syndrome (ACS) |
| Intervention type | Drug |
| Interventions | Sertraline (Zoloft), Simvastatin (Zocor) |
| Enrollment | 7 |
| Start date | Apr 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | May 31, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: